Rituximab Plus Avacopan increases remission rates in ANCA-associated vasculitis
Anisha Dua, MD, MPH Credit: American College of Rheumatology Convergence Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab (RTX) showed a significantly higher remission rate, which was …